Developer docs
API playgroundTry for free, no card

Search company profiles

BIOCANN LTD

Full company profile

uuid02ieme5

Namestring
BIOCANN LTD
Legal namestring
BioCann (Pty) Ltd
Websiteurl
bio-cann.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

BioCann LTD, operating as BioCann (Pty) Ltd, is a South African medical cannabis cultivator founded in 2019 and headquartered in Cape Town, with its principal cultivation and processing operation on a 100-hectare farm in Limpopo province. The company runs what it claims is the largest commercial indoor cannabis facility in South Africa, spanning over 3,500 square meters with capacity to grow at least 50,000 plants annually across seven licensed hectares. Cultivation operates under Good Agricultural and Collection Practice (GACP), processing under Good Manufacturing Practice (GMP), and both facilities hold Control Union Medical Cannabis Standard (CUMCS) certification, with SAHPRA compliance achieved in 2020 as one of the country's first licensed producers.

BioCann's product offering is built on an exclusive genetics partnership with Segra International, a global cannabis plant genetics company, providing Health Canada-registered strains with digital traceability for pharmaceutical-grade consistency. The company has imported EU-GMP equipment and is preparing for inspection to unlock premium European and Australian export markets.

The business model is B2B pharmaceutical export of medical-grade cannabis flower to licensed partners in Germany, the UK, and Australia, supplemented by local South African patient access under Section 21 of the Medicines and Related Substances Act. The company also runs a sponsorship program providing free medical-grade cannabis to cancer patients. Revenue is generated through quote-based B2B pharmaceutical supply contracts; no pricing or revenue figures are publicly disclosed. The leadership team includes a Lead Cultivator with a Master's in Horticulture and a Research Scientist with a Ph.D. in Plant Genetics.

Short descriptiontext

BioCann is a South African medical cannabis cultivator operating the country's largest commercial indoor facility on a 100-hectare Limpopo farm, exporting pharmaceutical-grade flower to licensed partners in Germany, the UK, and Australia under SAHPRA, CUMCS, and pending EU-GMP certifications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCape Town, South Africa
HQ citystring
Cape Town
HQ countrystring
South Africa
HQ regionstring
Africa
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis cultivation, cannabis processing services, pharmaceutical cannabis export, cannabis genetics supply, GACP certified cultivation
Industry1 code
PRIMARYAFAGAGAE
Medicinal Plant Farming (Botanical/Pharmaceutical Crops)
Agriculture & Food Production/Crop Farming/Specialty & Industrial Crop Farming (Tobacco, Hops, Spices, Medicinal/Aromatic Plants)
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code2 codes
  • Agricultural Production-Crops100
  • Medicinal Chemicals & Botanical Products2833
Product category
Medical Cannabis Cultivation
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Cannabis Export
TypeTransaction Fee
Description

Export of premium medical cannabis flower and products to international pharmaceutical companies in Germany, UK, and Australia. B2B revenue through pharmaceutical supply relationships.

bio-cann.com
2Local South African Market
TypeSubscription Recurring
Description

Development of local patient access in accordance with Section 21 of Medicines and Related Substances Act 101 of 1965. Also provides medical-grade cannabis free of charge to local cancer patients through sponsorship program.

bio-cann.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

BioCann cultivates, processes, and supplies medical-grade cannabis from a 3,500 square meter indoor facility on a 100-hectare farm in Limpopo Province, South Africa. The company operates seven licensed hectares with capacity to grow at least 50,000 cannabis plants annually, exporting premium flower to international pharmaceutical companies in Germany, the UK, and Australia while supporting local patient access under Section 21 of the Medicines and Related Substances Act.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 610+ trusted clients
+2 more records
Product overview1 text field

BioCann is a medical cannabis cultivator offering a vertically integrated service portfolio centered on premium medical cannabis cultivation. The core offerings include Premium Medical Cannabis Cultivation (indoor facility spanning 3,500+ square meters, growing 50,000+ plants annually) and Medical Grade Supply products, with both cultivation and processing facilities certified under GACP and GMP standards respectively. All products are powered by genetics partnership with Segra International. The company exports to Germany, UK, and Australia while developing the local South African medical cannabis market.

Product and service4 records
1Premium Medical Cannabis Cultivation
CategoryCannabis Cultivation
Description

Indoor cannabis cultivation services producing premium strains that exceed global quality standards, supplied to international pharmaceutical companies and export markets including Germany, UK, and Australia.

2Medical Grade Supply
CategoryCannabis Supply
Description

Medical-grade cannabis products meeting stringent quality standards, providing reliable premium products for medical use by licensed pharmaceutical and medical partners.

3Cannabis Cultivation Services
CategoryCannabis Cultivation
Description

Indoor cultivation facility spanning over 3,500 square meters capable of growing at least 50,000 cannabis plants annually, operating under Good Agricultural and Collection Practice (GACP) standards.

4Cannabis Processing Services
CategoryCannabis Processing
Description

Processing facility managed under Good Manufacturing Practice (GMP) standards, certified under the Control Union Medical Cannabis Standard (CUMCS) for post-cultivation processing of medical cannabis.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

BioCann's product offering is uniquely powered by its partnership with Segra International – a global leader in cannabis plant genetics. Equipped with superior strains and combined with BioCann's extensive knowledge and innovative technology, this partnership ensures production of exceptional medical cannabis products.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Canadian cannabis major with EU GMP-certified production and international medical cannabis distribution. Operates in overlapping product/customer categories as BioCann but at much larger scale.

TypeBroad incumbent
Description

Canadian cannabis major with international medical cannabis operations and European distribution. Comparable industry positioning to BioCann but as a diversified incumbent with significantly broader product portfolio.

TypeDirect peer
Description

Canadian GMP-certified cannabis extracts manufacturer supplying pharmaceutical partners internationally. Comparable to BioCann in its GMP-certified processing focus and B2B pharmaceutical channel strategy.

TypeBroad incumbent
Description

Canadian medical cannabis producer with international supply capabilities and pharmaceutical partnerships. Comparable medical-grade cultivation focus though with broader product range and established capital markets access.

TypeDirect peer
Description

Colombian-based medical cannabis cultivator with EU GMP-certified operations and a B2B export model targeting European pharmaceutical buyers. Closely comparable to BioCann's vertical integration, EU GMP focus, and international export strategy.

TypeDirect peer
Description

Latin American medical cannabis cultivator with established European distribution and a pharmaceutical-aligned B2B model. Comparable to BioCann in its cultivation-to-pharma-export approach and regulatory positioning for premium markets.

7Tilray
TypeBroad incumbent
Description

Major international cannabis producer with EU GMP-certified operations and established pharmaceutical supply relationships across Germany and other European markets. Overlaps with BioCann's medical cannabis export business but operates at much larger scale.

TypeBroad incumbent
Description

International cannabis operator with medical-grade production and global distribution. Comparable in international medical cannabis positioning though at significantly larger scale and broader geographic footprint.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BIOCANN LTD

Medical Cannabis Cultivationbio-cann.com

BioCann is a South African medical cannabis cultivator operating the country's largest commercial indoor facility on a 100-hectare Limpopo farm, exporting pharmaceutical-grade flower to licensed partners in Germany, the UK, and Australia under SAHPRA, CUMCS, and pending EU-GMP certifications.

What BIOCANN LTD does

BioCann LTD, operating as BioCann (Pty) Ltd, is a South African medical cannabis cultivator founded in 2019 and headquartered in Cape Town, with its principal cultivation and processing operation on a 100-hectare farm in Limpopo province. The company runs what it claims is the largest commercial indoor cannabis facility in South Africa, spanning over 3,500 square meters with capacity to grow at least 50,000 plants annually across seven licensed hectares. Cultivation operates under Good Agricultural and Collection Practice (GACP), processing under Good Manufacturing Practice (GMP), and both facilities hold Control Union Medical Cannabis Standard (CUMCS) certification, with SAHPRA compliance achieved in 2020 as one of the country's first licensed producers.

BioCann's product offering is built on an exclusive genetics partnership with Segra International, a global cannabis plant genetics company, providing Health Canada-registered strains with digital traceability for pharmaceutical-grade consistency. The company has imported EU-GMP equipment and is preparing for inspection to unlock premium European and Australian export markets.

The business model is B2B pharmaceutical export of medical-grade cannabis flower to licensed partners in Germany, the UK, and Australia, supplemented by local South African patient access under Section 21 of the Medicines and Related Substances Act. The company also runs a sponsorship program providing free medical-grade cannabis to cancer patients. Revenue is generated through quote-based B2B pharmaceutical supply contracts; no pricing or revenue figures are publicly disclosed. The leadership team includes a Lead Cultivator with a Master's in Horticulture and a Research Scientist with a Ph.D. in Plant Genetics.

BIOCANN LTD firmographics

Firmographics
Name
BIOCANN LTD
Legal name
BioCann (Pty) Ltd
Website
https://bio-cann.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
BioCann is a South African medical cannabis cultivator operating the country's largest commercial indoor facility on a 100-hectare Limpopo farm, exporting pharmaceutical-grade flower to licensed partners in Germany, the UK, and Australia under SAHPRA, CUMCS, and pending EU-GMP certifications.
Ownership category
akta.pro rank

BIOCANN LTD industry classification

Industry
Product category
Medical Cannabis Cultivation
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Agricultural Production-Crops (100), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYAFAGAGAE
Medicinal Plant Farming (Botanical/Pharmaceutical Crops)
Agriculture & Food Production/Crop Farming/Specialty & Industrial Crop Farming (Tobacco, Hops, Spices, Medicinal/Aromatic Plants)

Keywords

  • Medical cannabis cultivation
  • Cannabis processing services
  • Pharmaceutical cannabis export
  • Cannabis genetics supply
  • GACP certified cultivation

Where BIOCANN LTD is headquartered

Location

Headquarters

HQ city
Cape Town
HQ country
South Africa
HQ region
Africa

Offices2 records

Markets served

BIOCANN LTD business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Cannabis Export: Export of premium medical cannabis flower and products to international pharmaceutical companies in Germany, UK, and Australia. B2B revenue through pharmaceutical supply relationships.
  2. Local South African Market: Development of local patient access in accordance with Section 21 of Medicines and Related Substances Act 101 of 1965. Also provides medical-grade cannabis free of charge to local cancer patients through sponsorship program.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

BIOCANN LTD product offering

Product offering

Core offering

BioCann cultivates, processes, and supplies medical-grade cannabis from a 3,500 square meter indoor facility on a 100-hectare farm in Limpopo Province, South Africa. The company operates seven licensed hectares with capacity to grow at least 50,000 cannabis plants annually, exporting premium flower to international pharmaceutical companies in Germany, the UK, and Australia while supporting local patient access under Section 21 of the Medicines and Related Substances Act.

Product overview

BioCann is a medical cannabis cultivator offering a vertically integrated service portfolio centered on premium medical cannabis cultivation. The core offerings include Premium Medical Cannabis Cultivation (indoor facility spanning 3,500+ square meters, growing 50,000+ plants annually) and Medical Grade Supply products, with both cultivation and processing facilities certified under GACP and GMP standards respectively. All products are powered by genetics partnership with Segra International. The company exports to Germany, UK, and Australia while developing the local South African medical cannabis market.

Differentiator

Problem solved

Functional benefit

Products and services

  • Premium Medical Cannabis Cultivation Indoor cannabis cultivation services producing premium strains that exceed global quality standards, supplied to international pharmaceutical companies and export markets including Germany, UK, and Australia.
  • Medical Grade Supply Medical-grade cannabis products meeting stringent quality standards, providing reliable premium products for medical use by licensed pharmaceutical and medical partners.
  • Cannabis Cultivation Services Indoor cultivation facility spanning over 3,500 square meters capable of growing at least 50,000 cannabis plants annually, operating under Good Agricultural and Collection Practice (GACP) standards.
  • Cannabis Processing Services Processing facility managed under Good Manufacturing Practice (GMP) standards, certified under the Control Union Medical Cannabis Standard (CUMCS) for post-cultivation processing of medical cannabis.

Quantifiable outcome

  • 610+ trusted clients
  • +2 more outcomes

Companies that use BIOCANN LTD

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

BIOCANN LTD technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

BIOCANN LTD partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Segra InternationalcoreTechnology or IntegrationBioCann's product offering is uniquely powered by its partnership with Segra International – a global leader in cannabis plant genetics. Equipped with superior strains and combined with BioCann's extensive knowledge and innovative technology, this partnership ensures production of exceptional medical cannabis products.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

BIOCANN LTD competitors and assessment

Company assessment

Broad incumbents

  • Aurora Cannabis: Canadian cannabis major with EU GMP-certified production and international medical cannabis distribution. Operates in overlapping product/customer categories as BioCann but at much larger scale.
  • Canopy Growth: Canadian cannabis major with international medical cannabis operations and European distribution. Comparable industry positioning to BioCann but as a diversified incumbent with significantly broader product portfolio.
  • OrganiGram Holdings: Canadian medical cannabis producer with international supply capabilities and pharmaceutical partnerships. Comparable medical-grade cultivation focus though with broader product range and established capital markets access.
  • Tilray: Major international cannabis producer with EU GMP-certified operations and established pharmaceutical supply relationships across Germany and other European markets. Overlaps with BioCann's medical cannabis export business but operates at much larger scale.
  • Cronos Group: International cannabis operator with medical-grade production and global distribution. Comparable in international medical cannabis positioning though at significantly larger scale and broader geographic footprint.

Direct peers

  • MediPharm Labs: Canadian GMP-certified cannabis extracts manufacturer supplying pharmaceutical partners internationally. Comparable to BioCann in its GMP-certified processing focus and B2B pharmaceutical channel strategy.
  • Clever Leaves: Colombian-based medical cannabis cultivator with EU GMP-certified operations and a B2B export model targeting European pharmaceutical buyers. Closely comparable to BioCann's vertical integration, EU GMP focus, and international export strategy.
  • Khiron Life Sciences: Latin American medical cannabis cultivator with established European distribution and a pharmaceutical-aligned B2B model. Comparable to BioCann in its cultivation-to-pharma-export approach and regulatory positioning for premium markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

BIOCANN LTD social profiles

Digital presence

BIOCANN LTD compliance and trust

Trust signal

Compliance4 records

BIOCANN LTD financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BIOCANN LTD leadership team

Management profile

Number of profiles

Profiles2 records

BIOCANN LTD funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BIOCANN LTD M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOCANN LTD

What does BIOCANN LTD do?

BioCann cultivates, processes, and supplies medical-grade cannabis from a 3,500 square meter indoor facility on a 100-hectare farm in Limpopo Province, South Africa. The company operates seven licensed hectares with capacity to grow at least 50,000 cannabis plants annually, exporting premium flower to international pharmaceutical companies in Germany, the UK, and Australia while supporting local patient access under Section 21 of the Medicines and Related Substances Act.

Is BIOCANN LTD a public or private company?

BIOCANN LTD is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BIOCANN LTD founded?

BIOCANN LTD was founded in 2019. It employs 11 to 50 people.

Where is BIOCANN LTD based?

BIOCANN LTD is headquartered in Cape Town, South Africa, in the Africa region.

How does BIOCANN LTD make money?

Two revenue lines are on record. Medical Cannabis Export is the primary driver. The others are local South African Market.

Who are BIOCANN LTD's main competitors?

Broad incumbents on record are Aurora Cannabis, Canopy Growth, OrganiGram Holdings, Tilray and Cronos Group. Direct peers are MediPharm Labs, Clever Leaves and Khiron Life Sciences.

Does BIOCANN LTD have an API?

No public API is recorded for BIOCANN LTD.

What industry is BIOCANN LTD in?

BIOCANN LTD's product category is Medical Cannabis Cultivation. Its primary akta.pro industry code is AFAGAGAE, Medicinal Plant Farming (Botanical/Pharmaceutical Crops). Its NAICS code is 325411 and its SIC code is 100.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales